Domov › Intersticijske pljučne bolezni › New York › New York City
Klinične študije za Intersticijske pljučne bolezni v New York City, NY
18 študij za Intersticijske pljučne bolezni išče udeležence na lokacijah v New York City in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Vključevanje udeležencevFaza 3
- Weill Cornell Medicine-New York-60569, New York
- Columbia University Medical Center-New York Presbyterian Hospital, New York
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Vključevanje udeležencevFaza 3
- Weill Cornell Medicine-New York-60569, New York
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Vključevanje udeležencevFaza 2
- NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Weill Cornell Medicine, New York
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Vključevanje udeležencevFaza 3
- USA005, New York
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Vključevanje udeležencevFaza 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Vključevanje udeležencevFaza 3
- GSK Investigational Site, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Vključevanje udeležencevFaza 3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Vključevanje udeležencevFaza 2/3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Vključevanje udeležencevFaza 2
- Icahn School of Medicine at Mount Sinai, New York
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Vključevanje udeležencev
- Weill Cornell University Medical College, New York
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Vključevanje udeležencevFaza 3
- NYU Langone Health, New York
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Vključevanje udeležencevOpazovalna študija
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital - Weill Cornell Medicine, New York
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Vključevanje udeležencevOpazovalna študija
- Weill Cornell Medicine, New York
Platform Clinical Study for Conquering Scleroderma
Vključevanje udeležencevFaza 2
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Vključevanje udeležencevFaza 2/3
- Columbia University Irving Medical Center, New York
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Vključevanje udeležencevOpazovalna študija
- Weill Medical College of Cornell University, New York
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Vključevanje udeležencevFaza 3
- Weill Cornell Medicine, New York-Presbyterian Hospital, New York
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Vključevanje udeležencevFaza 2
- aTyr Investigative Site, New York
Študije za Intersticijske pljučne bolezni v drugih mestih
- Philadelphia, PA16 študij
- Los Angeles, CA14 študij
- Charleston, SC13 študij
- Kansas City, KS13 študij
- Durham, NC13 študij
- Chicago, IL12 študij
- Houston, TX12 študij
- Aurora, CO11 študij
- Ann Arbor, MI11 študij
- Salt Lake City, UT9 študij
- Dallas, TX9 študij
- Boston, MA9 študij
Druge študije v New York City
- Rak dojke136 študij
- Nemalicelični pljučni rak121 študij
- Rak (vse vrste)109 študij
- Rak prostate103 študij
- Metastatski rak93 študij
- Kolorektalni rak78 študij
- Rak jajčnikov69 študij
- Rak pljuč60 študij
- Množni mielom60 študij
- Rak trebušne slinavke60 študij
- Rak endometrija52 študij
- Akutna mieločna levkemija51 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.